Clinical Trials
0
Active:0
Completed:0
Trial Phases
0 Phases
Drug Approvals
4
NMPA:4
Drug Approvals
Labetalol Hydrochloride Injection
- Product Name
- 盐酸拉贝洛尔注射液
- Approval Number
- 国药准字H20254451
- Approval Date
- Jun 3, 2025
NMPA
Nitroglycerin Sublingual Tablets
- Product Name
- 硝酸甘油舌下片
- Approval Number
- 国药准字H20253630
- Approval Date
- Mar 18, 2025
NMPA
Esmolol Hydrochloride Injection
- Product Name
- 盐酸艾司洛尔注射液
- Approval Number
- 国药准字H20244265
- Approval Date
- Jun 28, 2024
NMPA
Cisatracurium Besylate Injection
- Product Name
- 苯磺顺阿曲库铵注射液
- Approval Number
- 国药准字H20233917
- Approval Date
- Jul 6, 2023
NMPA
Clinical Trials
No trials found
News
No news found